about
Mitochondrial dysfunction in Parkinson's diseaseThe Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-AnalysisGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinTraumatic brain injury and NADPH oxidase: a deep relationshipMagnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.Neurodegenerative changes initiated by presynaptic dysfunction.Alteration of dynein function affects α-synuclein degradation via the autophagosome-lysosome pathway.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.The pathomechanisms underlying Parkinson's disease.Interactions between calcium and alpha-synuclein in neurodegeneration.In vitro dopaminergic neurotoxicity of pesticides: a link with neurodegeneration?How many biomarkers to discriminate neurodegenerative dementia?α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.α-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation.TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells.Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL/6 mice.
P2860
Q26741872-CFA47058-AEF3-4901-9CE3-046E7D1192C6Q26785974-E0620454-6483-48DA-8154-3B24080FC5A5Q27331743-58A719CB-54B3-4F58-ACFD-D7384F5052B8Q28080903-0D024234-CC33-437D-A536-013C74C18818Q30858994-A3F76608-78B3-4C77-BA95-4831307F21ADQ35994848-97691769-0731-428A-94D0-672F0797ABD2Q36333500-BF4B97CC-B5FB-4676-A535-367141A9CDEEQ37112980-0D4B713A-CA3C-42AC-BAD7-DE1DD9D71246Q37420985-1B8BADC8-001B-4D14-BB9D-AB6D89B7F1FEQ37702119-938F9781-D98C-4808-94AB-4CEACF7AF3B4Q38039857-9D489F46-9C46-4431-AE0C-9B54064514BDQ38182660-AD66557F-49C2-405E-97BA-F82D3AE5AD67Q38254376-CF32AF9E-042C-436C-B4B0-9E48847D30F5Q38288482-A7655712-6307-4B2A-89C2-6D2758DF9046Q38570242-16A1D256-3C35-495C-B7F3-59895315E50BQ38669019-0BB7E79D-00A6-44B1-B191-E951CDCBD7B9Q38947516-4D78947B-1AE8-41BE-A479-66190A06536DQ39852913-E4425E77-E24C-467F-BBC0-6D0F2098BB87Q42323946-4E9800CE-5D43-4546-86BE-1F9798FF5505Q47782213-1B695C9B-0CD1-4853-AF62-405866B5EC94Q47839262-3458F9CC-4AC9-46B6-9785-A95B6D0F7480Q52332617-5F5F6041-BB1B-4074-9D38-EE0B69645023Q53551633-0AC19968-6FAA-478F-9F2C-4052763F420E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
α-Synuclein and neuronal cell death.
@en
type
label
α-Synuclein and neuronal cell death.
@en
prefLabel
α-Synuclein and neuronal cell death.
@en
P2093
P2860
P921
P1476
α-Synuclein and neuronal cell death.
@en
P2093
Hideki Mochizuki
Toru Yasuda
Yasuto Nakata
P2860
P2888
P304
P356
10.1007/S12035-012-8327-0
P577
2012-08-31T00:00:00Z
2013-04-01T00:00:00Z
P5875
P6179
1020149430